Purchase Butylone
Discount program, second order - 5% OFF, third order - 7% OFF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy Butylone for sale
Butylone is an entactogen, psychedelic, and psychoactive stimulant drug of the phenethylamine chemical class. It is a substituted cathinone and the β-keto (substituted cathinone) analogue of MBDB.
Butylone is a substituted cathinone that emerged on the designer drug market in the early 2000s. It has been sold online and identified as an ingredient in recreational ecstasy tablets. Butylone, also known as β-keto-N-methylbenzodioxolylbutanamine (βk-MBDB), is an entactogen, psychedelic, and psychoactive stimulant drug of the phenethylamine chemical class.
Butylone is a substituted cathinone that emerged on the designer drug market in the early 2000s. It has been sold online and identified as an ingredient in recreational ecstasy tablets.
Butylone (bk-MBDB) is a substituted cathinone drug found in recreational pills sold as ecstasy. It is commonly known as ecstasy, a psychoactive drug that combines MDMA and Ketamine.
Butylone, commonly known as bk-MBDB and βk-MBDB, is a chemical from the family of drugs. This drug was used in the early 2000s in recreational tablets.
Butylone is the β-keto analogue of MBDB and the substituted methylenedioxyphenethylamine analogue of buphedrone. Chemically, it is closely related to ecstasy but has fewer psychedelic features and more stimulant properties.
Butylone is a synthetic stimulant sold online as a designer drug. It is closely related to methylone and MDMA but with little psychedelic activity.
Butylone is a chemical that is closely related to ecstasy. It produces stimulant effects, among other effects, when taken.
Buphedrone is a class B drug that can be injected intravenously or snorted; it is not orally active.
Butylone is a white crystalline powder with a slight smell and taste.
Butylone, commonly known as "bk-MBDB", is a stimulant drug of the 2C family that acts as a prodrug to both Butylone and Methylone. It was first detected in November 2010 following a sample that tested positive for MBDB, but subsequent testing determined it was bk-MBDB.
Butylone, also known as bk MBDB, is a stimulant in the 2C family. It acts as a prodrug for both Methylone and Butylone in the body. It is commonly distributed for recreational use as powder or capsule.
Butylone is a substituted cathinone and relative of Mephedrone and Methcathinone. It is also somewhat similar to MDMA (Ecstasy), with more euphoric and less stimulating effects, potentially lacking the stimulant qualities of other compounds in its class.
Butylone is a semi-synthetic psychedelic and entactogen of the phenethylamine group of compounds. It is related in structure to methylone and MDMA, with activity closer to MDA. This chemical was first synthesized in 1921 by Hoechst AG in Germany.
Butylone, also known as β-keto-N-methylbenzodioxolylbutanamine (βk-MBDB), is an entactogen and psychedelic drug of the phenethylamine class. It is the β-keto analogue of MBDB and the substituted methylenedioxyphenethylamine analogue of buphedrone.
Butylone (β-keto-N-methylbenzodioxolylbutanamine; βk-MBDB) is an entactogen, stimulant, and psychedelic drug of the phenethylamine chemical class. It is related to and has similar effects to methylone, slightly less potent than the parent compound.
Butylone is a psychoactive entactogen and stimulant of the phenethylamine, amphetamine, and cathinone chemical classes. It is structurally related to MDMA (ecstasy) and MDPV (methylone).
Butylone is a chemical compound of the substituted cathinone and substituted methylenedioxyphenethylamine classes. Butylone is active as an agonist at trace amine-associated receptor 1 (TAAR1), similar to the mechanism of action of MDMA, although with less selectivity.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics